Profile: Angiotech Pharmaceuticals, Inc. (ANPI.O)

Angiotech Pharmaceuticals, Inc. (Angiotech), is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from royalties derived from sales by its partners of products utilizing certain of its own technologies. The Company operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceuticals Technologies segment includes royalty revenue generated from licensing its paclitaxel technology to various partners. The Medical Products segment manufactures and markets a range of single use, specialty medical devices. The Medical Products segment also manufactures finished medical devices and medical device components for third party medical device manufacturers and marketers.

Pharmaceutical Technologies

The Company’s pharmaceutical technologies segment focuses primarily on establishing product development and marketing partnerships with major medical device, pharmaceutical or biomaterials companies. The principal revenues in this segment are from royalties derived from sales by Boston Scientific Corporation (BSC) of TAXUS coronary stent systems incorporating the drug paclitaxel.

Medical Products

The Medical Products segment manufactures and markets a range of single-use specialty medical products, primarily medical device products and medical device components. These products are sold directly to end users or other third party medical device manufacturers. This segment contains two specialized direct sales and distribution organizations as well as significant manufacturing capabilities. SKATER Drainage Catheters – the SKATER catheter line is used to facilitate drainage of fluid from wounds, infectious tissues or surgical sites, and features larger lumens and drainage holes, kink resistance, resistance to encrustation and high radiopacity. V+Pad Hemostatic Pad - the V+Pad product is a hydrophilic wound dressing that is intended for use in the local management of bleeding wounds such as vascular access sites (percutaneous catheters or tubes), surgical debridement and lacerations. The V+Pad provides rapid control of bleeding in patients on anticoagulation therapy and in patients following hemodialysis.

Soft Tissue Biopsy Needles, the Company offers, a range of soft tissue biopsy needles, both disposable and re-usable for use in different types of breast, lung, spinal and bone marrow biopsies. Bio Pince Full Core Biopsy Devices, bio pince is biopsy instrument product line featuring a tri-axial Cut and Trap cannula system. T- Lock Bone Marrow Biopsy Device, the Company’s bone marrow biopsy device, the T-Lock, has an ergonomically designed twist-lock handle, which improves a clinician’s ability to penetrate hard bone to obtain the biopsy sample. Hemo Stream Dialysis Catheter, this product is used for short-term vascular access for patients undergoing hemodialysis. Bio-Seal Lung Biopsy Tract Plug system, is designed to prevent air leaks in patients having lung biopsies. The Company’s general surgery products include, Quill SRS, Sharpoint Speciality Microsurgical products, Silk and polyester Braided and Monofilament suture materials, Drilled end and channel needles, Lifespan ePTFE vascular grafts and surgical blades used in cataract surgery.

The Company competes with Johnson & Johnson, Covidien, Inc., C.R. Bard Inc., Cardinal Health, Inc., Alcon, Inc. and Allergan, Inc.